Nucynta
These highlights do not include all the information needed to use NUCYNTA ER safely and effectively. See full prescribing information for NUCYNTA ER NUCYNTA ER (tapentadol) extended-release tablets for oral use C-II Initial U.S. Approval: 2008
40671852-846e-4bc1-8e15-1f71add24414
HUMAN PRESCRIPTION DRUG LABEL
Oct 22, 2018
Depo NF Sub, LLC
DUNS: 079790476
Products 5
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
tapentadol hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
tapentadol hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
tapentadol hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
tapentadol hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
tapentadol hydrochloride
Product Details
FDA regulatory identification and product classification information